102 related articles for article (PubMed ID: 21801962)
21. The role of a protease inhibitor against hepatectomy.
Gotohda N; Iwagaki H; Ozaki M; Konishi M; Nakagohri T; Takahashi S; Yagi T; Kinoshita T; Tanaka N
Hepatogastroenterology; 2006; 53(67):115-9. PubMed ID: 16506388
[TBL] [Abstract][Full Text] [Related]
22. [Enzymatic determination of a molar ratio of free branched-chain amino acids to tyrosine (BTR) and its clinical significance in plasma of patients with various liver diseases].
Nakamura T; Mori M; Yoshida T; Murakami N; Kato T; Sugihara J; Saito K; Moriwaki H; Tomita E; Muto Y
Rinsho Byori; 1989 Aug; 37(8):911-7. PubMed ID: 2585754
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for postoperative liver failure after hepatectomy for hepatocellular carcinoma.
Maeda Y; Nishida M; Takao T; Mori N; Tamesa T; Tangoku A; Oka M
Hepatogastroenterology; 2004; 51(60):1792-6. PubMed ID: 15532828
[TBL] [Abstract][Full Text] [Related]
24. Effect of hepatocyte growth factor on progression of liver metastasis in colorectal cancer.
Osada S; Matsui S; Komori S; Yamada J; Sanada Y; Ihawa A; Tanaka Y; Tokuyama Y; Okumura N; Nonaka K; Hosono Y; Takahashi T; Yamaguchi K; Yoshida K
Hepatogastroenterology; 2010; 57(97):76-80. PubMed ID: 20422876
[TBL] [Abstract][Full Text] [Related]
25. Assessment of preoperative exercise capacity in hepatocellular carcinoma patients with chronic liver injury undergoing hepatectomy.
Kaibori M; Ishizaki M; Matsui K; Nakatake R; Sakaguchi T; Habu D; Yoshiuchi S; Kimura Y; Kon AH
BMC Gastroenterol; 2013 Jul; 13():119. PubMed ID: 23875788
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma.
Chun JM; Kwon HJ; Sohn J; Kim SG; Park JY; Bae HI; Yun YK; Hwang YJ
J Surg Oncol; 2011 Feb; 103(2):148-51. PubMed ID: 21259248
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of serum HGF and c-Met expression in tumor tissue for evaluation of properties and treatment of hepatocellular carcinoma.
Osada S; Kanematsu M; Imai H; Goshima S
Hepatogastroenterology; 2008; 55(82-83):544-9. PubMed ID: 18613405
[TBL] [Abstract][Full Text] [Related]
28. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
Shiota G; Umeki K; Okano J; Kawasaki H
J Med; 1995; 26(5-6):295-308. PubMed ID: 8721905
[TBL] [Abstract][Full Text] [Related]
29. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
Shimozawa N; Hanazaki K
J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
[TBL] [Abstract][Full Text] [Related]
30. Supplementation of branched-chain amino acids maintains the serum albumin level in the course of hepatocellular carcinoma recurrence.
Kakazu E; Kondo Y; Kogure T; Ninomiya M; Kimura O; Iwata T; Morosawa T; Iwasaki T; Shimosegawa T
Tohoku J Exp Med; 2013 Aug; 230(4):191-6. PubMed ID: 23892757
[TBL] [Abstract][Full Text] [Related]
31. Prognostic effect of steatosis on hepatocellular carcinoma patients after liver resection.
Wu TH; Yu MC; Chan KM; Lee CF; Chen TC; Chang HC; Chou HS; Wu TJ; Eldeen FZ; Chen MF; Lee WC
Eur J Surg Oncol; 2011 Jul; 37(7):618-22. PubMed ID: 21640545
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of surgical complications and preoperative serum hepatocyte growth factor in hepatocellular carcinoma patients after initial hepatectomy.
Mizuguchi T; Nagayama M; Meguro M; Shibata T; Kaji S; Nobuoka T; Kimura Y; Furuhata T; Hirata K
J Gastrointest Surg; 2009 Feb; 13(2):325-33. PubMed ID: 18846405
[TBL] [Abstract][Full Text] [Related]
33. Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.
Dahiya D; Wu TJ; Lee CF; Chan KM; Lee WC; Chen MF
Surgery; 2010 May; 147(5):676-85. PubMed ID: 20004441
[TBL] [Abstract][Full Text] [Related]
34. Preoperative estimation of surgical risk of hepatectomy in cirrhotic patients.
Noguchi T; Imai T; Mizumoto R
Hepatogastroenterology; 1990 Apr; 37(2):165-71. PubMed ID: 2160419
[TBL] [Abstract][Full Text] [Related]
35. Serum transforming growth factor-alpha level can be a parameter for evaluating liver regeneration after partial hepatectomy in patients with liver cancer.
Tomiya T; Hayashi S; Yanase M; Umeda N; Tani M; Yamada S; Masaki N; Ogata I; Fujiwara K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-14-S6-17. PubMed ID: 9151911
[TBL] [Abstract][Full Text] [Related]
36. Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma.
Masuda T; Beppu T; Horino K; Komori H; Hayashi H; Okabe H; Otao R; Horlad H; Ishiko T; Takamori H; Kikuchi K; Baba H
J Surg Oncol; 2010 Oct; 102(5):490-6. PubMed ID: 19937994
[TBL] [Abstract][Full Text] [Related]
37. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease.
Cucchetti A; Ercolani G; Cescon M; Ravaioli M; Zanello M; Del Gaudio M; Lauro A; Vivarelli M; Grazi GL; Pinna AD
J Am Coll Surg; 2006 Nov; 203(5):670-6. PubMed ID: 17084328
[TBL] [Abstract][Full Text] [Related]
38. Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients.
Lau H; Fan ST; Ng IO; Wong J
Cancer; 1998 Dec; 83(11):2302-11. PubMed ID: 9840529
[TBL] [Abstract][Full Text] [Related]
39. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma.
Poon RT; Fan ST; Ng IO; Lo CM; Liu CL; Wong J
Cancer; 2000 Aug; 89(3):500-7. PubMed ID: 10931448
[TBL] [Abstract][Full Text] [Related]
40. Oral branched-chain amino acids administration improves impaired liver dysfunction after radiofrequency ablation therapy for hepatocellular carcinoma.
Ishikawa T; Michitaka I; Kamimura H; Higuchi K; Kubota T; Seki K; Ohta H; Yoshida T; Kamimura T
Hepatogastroenterology; 2009; 56(94-95):1491-5. PubMed ID: 19950815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
